INNOMED INNOVATION MEDICAL ApS: Financial statements 2024
CVR: 25139356
INNOMED INNOVATION MEDICAL ApS (CVR 25139356) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 249,592 and a net result of DKK 64,825 compared with DKK 97,212 the year before. That is a decrease of 18.2% compared with the year before. Equity amounted to DKK 343,218. The solvency ratio was 32.9%. The company had 3 employees in the financial year.
- Gross Profit
- 249,592 kr.
- Profit/Loss
- 64,825 kr.
- Equity
- 343,218 kr.
- Total Assets
- 1,043,038 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 250 t. | 65 t. | 343 t. | 3 |
| 2023 | - | 305 t. | 97 t. | 278 t. | 3 |
| 2022 | - | 180 t. | -41 t. | 181 t. | 2 |
| 2021 | - | 240 t. | 4 t. | 222 t. | 2 |
| 2020 | - | 420 t. | 158 t. | 218 t. | 2 |
How creditworthy is INNOMED INNOVATION MEDICAL ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
INNOMED INNOVATION MEDICAL ApS has published its annual report for 2023. Gross profit came to DKK 305,255, and the net result was DKK 97,212.
About INNOMED INNOVATION MEDICAL ApS
INNOMED INNOVATION MEDICAL ApS is a Danish company of the type Anpartsselskab based in Hirtshals, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens Kjeldgaard. The company is owned by Jens Kjeldgaard. The company has 3 employees. In 2025, the company reported a gross profit of DKK 248,225 and a net result of DKK 41,979 compared with DKK 64,825 the year before. Equity amounted to DKK 385,198.
